Adimarket, a Global Stem Cells Group subsidiary, has been named distributor in Latin America for Bioquark Biologic regenerative medicine products, developed for tissue and organ repair and regeneration.
Global Stem Cells Group subsidiary Adimarket has been named the Latin America distributor for Bioquark, Inc.’s biologic products for the regeneration and repair of human organs and tissues. The announcement is the latest in Global Stem Cells Group’s ambitious expansion plans in Latin America, a commitment made to meet the region’s growing demand for access to regenerative medicine and stem cell therapies.
Bioquark Inc. is focused on the development of biologics that have the ability to alter the regulatory state of human tissues and organs, with the goal of curing a range of chronic diseases, as well as affecting complex tissue regeneration. The biologic regulatory states of human cells, tissues and organs represent the central control processes behind disease, degeneration and aging.
Bioquark’s core program focuses on developing a singular class of substances, termed combinatorial biologics, which take a different approach to reversing underlying disease, degeneration or aging processes, as opposed to only effecting only the symptoms of these conditions.
Combinatorial biologics work at the level of the regulatory genome and are modeled off of biochemical dynamics found in various species that can naturally modify biologic regulatory states to achieve beneficial outcomes, such as complex tissue and organ regeneration, disease reversion, and even biological age reversal.
“The revolutionary work that Bioquark is performing is a perfect fit for Global Stem Cells Group’s vision of the potential that stem cell therapies hold, now and in the future,” says Ricardo DeCubas, Global Stem Cells Group co-founder and Cellgenic CEO.
The collaboration between Global Stem Cells Group, Adimarket and Bioquark is another step toward GSCG’s commitment to expanding its presence in communities that need and deserve access to cutting-edge regenerative medicine, not only in Latin America but also worldwide.
For more information visit the Global Stem Cells Group website, email bnovas@stemcellsgroup.com, or call 305-560-5337.
About Global Stem Cells Group:
Global Stem Cells Group, Inc. is the parent company of six wholly owned operating companies dedicated entirely to stem cell research, training, products and solutions. Founded in 2012, the company combines dedicated researchers, physician and patient educators and solution providers with the shared goal of meeting the growing worldwide need for leading edge stem cell treatments and solutions.
With a singular focus on this exciting new area of medical research, Global Stem Cells Group and its subsidiaries are uniquely positioned to become global leaders in cellular medicine. Global Stem Cells Group’s corporate mission is to make the promise of stem cell medicine a reality for patients around the world. Each of GSCG’s six operating companies focus on a separate research-based mission; the result is a global network of state-of-the-art stem cell treatments and facilities.
Global Stem Cells Group is a publicly traded company operating under the symbol MSSV. https://finance.yahoo.com/quote/mssv/
About Bioquark, Inc.
Founded in 2007, Bioquark, Inc. is a life sciences company developing proprietary combinatorial biologic products for both the regeneration and repair of human organs and tissues. The company’s core program is focused on the development of novel combinatorial biologics capable of directly remodeling diseased, damaged, or aged tissues, and creating micro-environments that induce efficient and controllable regeneration and repair.
Through an innovative approach to biologic regulatory state modification, Bioquark researchers are capable of creating dynamics in mature tissues that are normally only seen during human fetal development, as well as during limb and organ regeneration in organisms like amphibians.
Developed as biologics, Bioquark’s therapeutics will be more amenable to existing regulatory pathways than other cell technologies, and able to circumvent many limitations in the industry’s current offerings.
About Adimarket:
Adimarket, Inc., a division of the Global Stem Cells Group, is a cost-competitive online marketplace for quality regenerative medicine equipment and supplies for physicians and health care professionals.
Adimarket was founded to provide physicians and other health care professionals the tools they need to practice regenerative medicine in a medical office setting. Motivated by a firm belief in the impact the practice of stem cell medicine can have when dispensed in a doctor’s office, Adimarket provides physicians with the tools they need to provide patients with cutting edge treatments.
